南模生物
(688265)
| 流通市值：11.61亿 | | | 总市值：18.33亿 |
| 流通股本：4938.85万 | | | 总股本：7796.35万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 67,932,808.65 | 107,867,774.76 | 108,343,188.5 | 97,602,921.4 |
| 应收票据及应收账款 | 120,033,157.58 | 125,933,788.36 | 128,010,514.23 | 108,120,892.85 |
| 其中：应收票据 | - | 871,528 | - | 85,288 |
| 应收账款 | 120,033,157.58 | 125,062,260.36 | 128,010,514.23 | 108,035,604.85 |
| 预付款项 | 2,229,043.52 | 1,218,851.09 | 2,324,129.12 | 693,623.87 |
| 其他应收款合计 | 2,807,808.64 | 3,609,143.1 | 4,628,868.13 | 4,985,988.22 |
| 存货 | 17,407,503.63 | 15,399,865.14 | 16,853,575.55 | 15,828,142.53 |
| 其他流动资产 | 10,842,822.68 | 9,067,591.49 | 8,210,811.33 | 11,619,532.37 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,086,358,495.97 | 1,136,355,680.96 | 1,134,690,540.6 | 1,166,135,742.41 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 58,475,189.68 | 55,475,189.68 | 54,475,189.68 | 54,475,189.68 |
| 固定资产 | 268,616,161.65 | 275,678,857.97 | 277,822,317.71 | 284,464,584.85 |
| 在建工程 | 67,011,890.69 | 66,634,532.2 | 66,634,532.2 | 61,272,146.88 |
| 使用权资产 | 67,778,264.22 | 73,974,706.64 | 80,605,064.05 | 85,796,409.39 |
| 无形资产 | 241,183,180.88 | 242,396,826.59 | 243,778,135.76 | 245,283,911.25 |
| 长期待摊费用 | 63,142,972.18 | 65,724,599.59 | 70,021,768.36 | 74,501,942.72 |
| 递延所得税资产 | 26,958,533.35 | 25,048,027.92 | 21,630,140.65 | 20,929,190.04 |
| 其他非流动资产 | 2,794,345.28 | 2,804,831.81 | 3,666,528.73 | 4,909,323.96 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 795,960,537.93 | 807,737,572.4 | 818,633,677.14 | 831,632,698.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,882,319,033.9 | 1,944,093,253.36 | 1,953,324,217.74 | 1,997,768,441.18 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 22,982,096.62 | 32,741,869.67 | 30,486,400.07 | 32,929,407.01 |
| 应付账款 | 22,982,096.62 | 32,741,869.67 | 30,486,400.07 | 32,929,407.01 |
| 合同负债 | 86,738,265.41 | 90,662,947.25 | 91,618,199.06 | 90,744,943.81 |
| 应付职工薪酬 | 19,113,144.09 | 23,565,303.05 | 16,897,848.7 | 27,124,051.83 |
| 应交税费 | 2,556,132.2 | 990,209.61 | 930,679.66 | 1,322,709.32 |
| 其他应付款合计 | 3,190,713.73 | 1,770,394.2 | 1,607,883.53 | 2,021,836.44 |
| 一年内到期的非流动负债 | 20,329,056.57 | 25,295,143.08 | 25,185,867.85 | 25,848,170.22 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 154,909,408.62 | 175,025,866.86 | 166,726,878.87 | 179,991,118.63 |
| 非流动负债: | | | | |
| 租赁负债 | 56,907,043.31 | 58,807,736.67 | 65,217,996.99 | 68,907,700.18 |
| 递延收益 | 9,749,924.64 | 10,329,653.55 | 11,069,382.46 | 11,649,111.37 |
| 递延所得税负债 | 843,010.43 | 571,748.08 | 1,036,552.47 | 437,124.95 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 67,499,978.38 | 69,709,138.3 | 77,323,931.92 | 80,993,936.5 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 222,409,387 | 244,735,005.16 | 244,050,810.79 | 260,985,055.13 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,963,513 | 77,963,513 | 77,963,513 | 77,963,513 |
| 资本公积 | 1,564,480,642.71 | 1,563,327,145.68 | 1,570,770,422.95 | 1,568,219,766.64 |
| 减:库存股 | 62,086,095.9 | 37,941,554.59 | 31,450,876.16 | 14,378,424.38 |
| 其他综合收益 | -177,534.01 | 224,171.09 | -41,138.38 | 49,984.55 |
| 盈余公积 | 17,735,223.2 | 17,735,223.2 | 17,735,223.2 | 17,735,223.2 |
| 未分配利润 | 61,993,897.9 | 78,049,749.82 | 74,296,262.34 | 87,193,323.04 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,659,909,646.9 | 1,699,358,248.2 | 1,709,273,406.95 | 1,736,783,386.05 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,659,909,646.9 | 1,699,358,248.2 | 1,709,273,406.95 | 1,736,783,386.05 |
| 负债和股东权益合计 | 1,882,319,033.9 | 1,944,093,253.36 | 1,953,324,217.74 | 1,997,768,441.18 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |